ERG expression can predict the outcome of docetaxel combinedwith androgen deprivation therapy in metastatic hormone-sensitiveprostate cancer

Küronya, Zsófia and Sükösd, Farkas and Varga, Linda and Bíró, Krisztina and Gyergyay, Fruzsina and Géczi, Lajos and Nagyiványi, Krisztián and Jorgo, Kliton and Szarvas, Tibor and Kovács, Ágnes and Laczó, Ibolya and Varga, Zoltán and Pósfai, Boglárka and Pepó, Judit and Maráz, Anikó (2019) ERG expression can predict the outcome of docetaxel combinedwith androgen deprivation therapy in metastatic hormone-sensitiveprostate cancer. Urologic Oncology, 37 (4). 289.e1-289.e9. ISSN 1078-1439

Text Küronya_ERG expression can predict the outcome of docetaxel combinedwith androgen deprivation therapy in metastatic hormone-sensitiveprostate cancer..pdf Restricted to Registered users only Download (1MB)

Item Type:	Article
Subjects:	R Medicine / orvostudomány > RC Internal medicine / belgyógyászat > RC0254 Neoplasms. Tumors. Oncology (including Cancer) / daganatok, tumorok, onkológia R Medicine / orvostudomány > RZ Other systems of medicine / orvostudomány egyéb területei
Depositing User:	Dr. habil. Tibor Szarvas
Date Deposited:	13 Sep 2019 07:39
Last Modified:	13 Sep 2019 07:39
URI:	http://real.mtak.hu/id/eprint/99282

Available Versions of this Item

• ERG expression can predict the outcome of docetaxel combinedwith androgen deprivation therapy in metastatic hormone-sensitiveprostate cancer. (deposited 13 Sep 2019 07:57)
  • ERG expression can predict the outcome of docetaxel combinedwith androgen deprivation therapy in metastatic hormone-sensitiveprostate cancer. (deposited 13 Sep 2019 07:39) [Currently Displayed]

Actions (login required)

Edit Item